Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Trevi Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 80 | 77 | −3 |
| Shares | 51.6M | 55.9M | +4.35M (+8.4%) |
| Value | $177.9M | $166.6M | −$11.3M (−6.3%) |
New holders (6)
Institutions that held Trevi Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 1,474,926 | $4.40M | 2.62% |
| Acuta Capital Partners, LLC | 260,000 | $774.8K | 0.65% |
| Corebridge Financial, Inc. | 31,595 | $94.2K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 21,151 | $63.0K | 0.00% |
| HSBC Holdings PLC | 19,612 | $60.8K | 0.00% |
| Alliancebernstein L.P. | 15,440 | $46.0K | 0.00% |
Sold out (9)
Institutions that held Trevi Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Atom Investors LP | 45,736 | $157.8K |
| Citadel Advisors LLC | 28,680 | $98.9K |
| American International Group, Inc. | 20,773 | $71.7K |
| Jump Financial, LLC | 18,441 | $63.6K |
| Squarepoint Ops LLC | 15,027 | $51.8K |
| SG Americas Securities, LLC | 14,592 | $50.0K |
| Metropolitan Life Insurance Co | 2,335 | $8.06K |
| Steward Partners Investment Advisory, LLC | 25 | $86 |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 6 | $20 |